Co-foundedin2017bytwopioneersingenomeeditingtechnology,QihanBiotechhasworld-leadingcapabilitiesinmultiplexablegenomeeditingaswellasvastexperienceinImmuneshielding.Weapplythesetoolsinbothhumanstemcellsandanimalgermlinecellstodelivernovelimmune-privilegedcellandorgantherapies.